0 avis
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
Archive ouverte
International audience. Background Biomarker-based risk predictions of dementia in people with mild cognitive impairment are highly relevant for care planning and to select patients for treatment when disease-modifying drugs become available. We aimed to establish robust prediction models of disease progression in people at risk of dementia.